Addiction Treatment
Addiction Treatment RSS Feed RSS

Treating Addiction in Patients Transitioning to/from Incarceration

August 1, 2019
Karen Cropsey, PsyD
Karen Cropsey, PsyDKaren Cropsey, PsyD

Conatser Turner Endowed Professor of Psychiatry, University of Alabama at Birmingham. 

Dr. Cropsey has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Addiction treatment during incarceration is limited, and release from incarceration presents its own set of challenges. In this QA interview, Dr. Karen Cropsey discusses effective treatment options for patients with substance use disorders transitioning to or from incarceration.
Read More

New Generic Versions of Naloxone

August 1, 2019
Talia Puzantian, PharmD, BCPP.
Talia Puzantian, PharmD, BCPP. Dr. Puzantian has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Naloxone, a rescue medication effective for reversing opioid overdose, will soon be available in two generic forms for layperson use. This news of note summarizes these generic, lower-cost products.
Read More

Opioid Use Disorder: Is There an App for That?

August 1, 2019
Joshua Sonkiss, MD.
Joshua Sonkiss, MD. Dr. Sonkiss has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
This News of Note discusses the first FDA-approved mobile app for SUDs, called reSET-O. Classified as a mobile medical app (MMAs), reSET-O can be used as an adjunct to outpatient opioid use disorder treatment. Unlike most apps, reSET-O requires a prescription to unlock and use.
Read More

Gabapentin Enacarbil XR Efficacy Less Than Expected for AUD

August 1, 2019
Thomas Jordan, MD
Thomas Jordan, MD Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
This 2019 randomized, double-blind, placebo- controlled trial study casts doubt on using gabapentin enacarbil extended-release (GE-XR) (Horizant), an extended-release version of gabapentin, for treatment in patients with alcohol use disorder
Read More

Managing Substance-Related Agitation

May 21, 2019
Thomas Jordan, MD, MPH
Thomas Jordan, MD, MPH Contributing writer to the Carlat newsletters. Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
In emergency departments, psychiatrists are often consulted on patients presenting with agitation. In many cases, these patients are under the influence of substances—either from intoxication or withdrawal.
Read More

Treating Co-Occurring Psychiatric Disorders

May 21, 2019
Stephen Ross, MD
Stephen Ross, MD Stephen Ross, MD

Associate Professor of Psychiatry and Child & Adolescent Psychiatry at New York University School of Medicine. Director of Addiction Psychiatry, NYU Tisch Hospital.

Dr. Ross has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Just about any psychiatric disorder has a higher rate of addiction comorbidity than in the general population. The rates are even higher in treatment settings—more than 50% of people in addiction treatment settings will have a co-occurring psychiatric problem, and more than 50% in psychiatric settings will typically have a co-occurring Substance Use Disorder.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.